Veradermics, Inc Voting Outcome
Historical shareholder voting results from retained filings, including every disclosed proposal and director nominee. Vote counts are as filed, not split-adjusted, and displayed in K/M/B/T. — means the category was not reported or no vote was held. Frequency votes preserve each choice. All retained years remain available through pagination.
| Meeting / report date | Proposal / nominee | Outcome | For (shares) | Against (shares) | Abstain (shares) | Withheld (shares) | Broker non-votes (shares) | Filed | Frequency choices (shares) | Document |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|
| Indivior Pharmaceuticals, Inc. (INDV) | | $4.250B | 14.09 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|